 LOS ANGELES, April 20, 2021 PRNewswire -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Immunovant, Inc. Immunovant or the Company NASDAQ: IMVT for violations of 10b and 20a of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Companys securities between October 2, 2019 and February 1, 2021, inclusive the Class Period, are encouraged to contact the firm before April 20, 2021. 